The original lawsuit, filed in May, included four drugmakers: Purdue Pharma, the maker of OxyContin; Endo Pharmaceuticals, the maker of Percocet and Opana; Janssen Pharmaceuticals, the maker of fentanyl drug Duragesic; and Teva Pharmaceutical, a drugmaker that makes generic versions of pain medications.
The expanded complaint alleges the two largest drugstore chains failed to stop suspicious orders of opioids and dispensed unreasonable quantities of opioids from their pharmacies.
According to the complaint, CVS distributed 700 million opioid dosages in Florida between 2006 to 2014. In addition, one Walgreens distribution center supplied 285,800 orders of oxycodone in one month in a town of just 3,000 people.
“Defendants reaped billions of dollars in revenues while they knew, or should reasonably have known, that they were causing immense harm to the state and its citizens,” the lawsuit reads.
Read the full report here.
More articles on pharmacy:
AstraZeneca sells respiratory drug for $1.5B
Express Scripts to launch formulary for lower list price drugs
Nestle pays $98M for increased stake in food allergy drugmaker Aimmune
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
